Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 157

1.

Spontaneous coronary artery intramural hematoma in a patient with vascular Ehlers-Danlos syndrome: Serial findings in coronary computed tomographic angiography.

Toba T, Mori S, Yatani A, Sugisaki Y, Akita T, Sasaki N, Otake H, Shinke T, Mori H, Nishii T, Kono AK, Hirata KI.

J Cardiovasc Comput Tomogr. 2017 Jul - Aug;11(4):324-326. doi: 10.1016/j.jcct.2017.03.003. Epub 2017 Mar 21. No abstract available.

PMID:
28342678
2.

Cellular basis of burn-induced cardiac dysfunction and prevention by mesenteric lymph duct ligation.

Sambol J, Deitch EA, Takimoto K, Dosi G, Yatani A.

J Surg Res. 2013 Aug;183(2):678-85. doi: 10.1016/j.jss.2013.01.065. Epub 2013 Feb 22.

3.

Mesenteric lymph from rats with trauma-hemorrhagic shock causes abnormal cardiac myocyte function and induces myocardial contractile dysfunction.

Sambol JT, Lee MA, Jiang M, Dosi G, Dong W, Deitch EA, Yatani A.

J Appl Physiol (1985). 2011 Sep;111(3):799-807. doi: 10.1152/japplphysiol.00100.2011. Epub 2011 Jun 23.

4.

Role of gut-lymph factors in the induction of burn-induced and trauma-shock-induced acute heart failure.

Lee MA, Yatani A, Sambol JT, Deitch EA.

Int J Clin Exp Med. 2008;1(2):171-80. Epub 2008 Mar 31.

5.

Endoplasmic reticulum-mitochondria crosstalk in NIX-mediated murine cell death.

Diwan A, Matkovich SJ, Yuan Q, Zhao W, Yatani A, Brown JH, Molkentin JD, Kranias EG, Dorn GW 2nd.

J Clin Invest. 2009 Jan;119(1):203-12. doi: 10.1172/JCI36445. Epub 2008 Dec 8.

6.

Mesenteric lymph duct ligation prevents trauma/hemorrhage shock-induced cardiac contractile dysfunction.

Sambol JT, Lee MA, Caputo FJ, Kawai K, Badami C, Kawai T, Deitch EA, Yatani A.

J Appl Physiol (1985). 2009 Jan;106(1):57-65. doi: 10.1152/japplphysiol.90937.2008. Epub 2008 Nov 13.

7.

Inhibition of glycogen synthase kinase 3beta during heart failure is protective.

Hirotani S, Zhai P, Tomita H, Galeotti J, Marquez JP, Gao S, Hong C, Yatani A, Avila J, Sadoshima J.

Circ Res. 2007 Nov 26;101(11):1164-74. Epub 2007 Sep 27.

PMID:
17901358
8.

Glycogen synthase kinase-3alpha reduces cardiac growth and pressure overload-induced cardiac hypertrophy by inhibition of extracellular signal-regulated kinases.

Zhai P, Gao S, Holle E, Yu X, Yatani A, Wagner T, Sadoshima J.

J Biol Chem. 2007 Nov 9;282(45):33181-91. Epub 2007 Sep 12.

9.

Sphingosine 1-phosphate has dual functions in the regulation of endothelial cell permeability and Ca2+ metabolism.

Itagaki K, Yun JK, Hengst JA, Yatani A, Hauser CJ, Spolarics Z, Deitch EA.

J Pharmacol Exp Ther. 2007 Oct;323(1):186-91. Epub 2007 Jul 12.

PMID:
17626797
10.

Cellular mechanisms of burn-related changes in contractility and its prevention by mesenteric lymph ligation.

Kawai K, Kawai T, Sambol JT, Xu DZ, Yuan Z, Caputo FJ, Badami CD, Deitch EA, Yatani A.

Am J Physiol Heart Circ Physiol. 2007 May;292(5):H2475-84. Epub 2007 Jan 19.

11.

Down regulation of the L-type Ca2+ channel, GRK2, and phosphorylated phospholamban: protective mechanisms for the denervated failing heart.

Yatani A, Shen YT, Yan L, Chen W, Kim SJ, Sano K, Irie K, Vatner SF, Vatner DE.

J Mol Cell Cardiol. 2006 May;40(5):619-28.

PMID:
16600289
12.

Cardiac-specific overexpression of AT1 receptor mutant lacking G alpha q/G alpha i coupling causes hypertrophy and bradycardia in transgenic mice.

Zhai P, Yamamoto M, Galeotti J, Liu J, Masurekar M, Thaisz J, Irie K, Holle E, Yu X, Kupershmidt S, Roden DM, Wagner T, Yatani A, Vatner DE, Vatner SF, Sadoshima J.

J Clin Invest. 2005 Nov;115(11):3045-56.

13.

Dual effects of mesenteric lymph isolated from rats with burn injury on contractile function in rat ventricular myocytes.

Yatani A, Xu DZ, Irie K, Sano K, Jidarian A, Vatner SF, Deitch EA.

Am J Physiol Heart Circ Physiol. 2006 Feb;290(2):H778-85. Epub 2005 Oct 7.

14.

Paradoxical cellular Ca2+ signaling in severe but compensated canine left ventricular hypertrophy.

Song LS, Pi Y, Kim SJ, Yatani A, Guatimosim S, Kudej RK, Zhang Q, Cheng H, Hittinger L, Ghaleh B, Vatner DE, Lederer WJ, Vatner SF.

Circ Res. 2005 Sep 2;97(5):457-64. Epub 2005 Jul 28.

PMID:
16051885
15.

RhoA GTPase regulates L-type Ca2+ currents in cardiac myocytes.

Yatani A, Irie K, Otani T, Abdellatif M, Wei L.

Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H650-9. Epub 2004 Oct 7.

16.

Disruption of Rho signaling results in progressive atrioventricular conduction defects while ventricular function remains preserved.

Wei L, Taffet GE, Khoury DS, Bo J, Li Y, Yatani A, Delaughter MC, Klevitsky R, Hewett TE, Robbins J, Michael LH, Schneider MD, Entman ML, Schwartz RJ.

FASEB J. 2004 May;18(7):857-9. Epub 2004 Mar 19.

PMID:
15033930
17.

Insights into cardioprotection obtained from study of cellular Ca2+ handling in myocardium of true hibernating mammals.

Yatani A, Kim SJ, Kudej RK, Wang Q, Depre C, Irie K, Kranias EG, Vatner SF, Vatner DE.

Am J Physiol Heart Circ Physiol. 2004 Jun;286(6):H2219-28. Epub 2004 Feb 12.

18.
19.

Neurally-mediated increase in calcineurin activity regulates cardiac contractile function in absence of hypertrophy.

Li J, Yatani A, Kim SJ, Takagi G, Irie K, Zhang Q, Karoor V, Hong C, Yang G, Sadoshima J, Depre C, Vatner DE, West MJ, Vatner SF.

Cardiovasc Res. 2003 Sep 1;59(3):649-57.

PMID:
14499866
20.

Mechanism of enhanced cardiac function in mice with hypertrophy induced by overexpressed Akt.

Kim YK, Kim SJ, Yatani A, Huang Y, Castelli G, Vatner DE, Liu J, Zhang Q, Diaz G, Zieba R, Thaisz J, Drusco A, Croce C, Sadoshima J, Condorelli G, Vatner SF.

J Biol Chem. 2003 Nov 28;278(48):47622-8. Epub 2003 Sep 16.

21.

Type 5 adenylyl cyclase disruption alters not only sympathetic but also parasympathetic and calcium-mediated cardiac regulation.

Okumura S, Kawabe J, Yatani A, Takagi G, Lee MC, Hong C, Liu J, Takagi I, Sadoshima J, Vatner DE, Vatner SF, Ishikawa Y.

Circ Res. 2003 Aug 22;93(4):364-71. Epub 2003 Jul 17.

PMID:
12869393
22.

Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy.

Yamamoto S, Yang G, Zablocki D, Liu J, Hong C, Kim SJ, Soler S, Odashima M, Thaisz J, Yehia G, Molina CA, Yatani A, Vatner DE, Vatner SF, Sadoshima J.

J Clin Invest. 2003 May;111(10):1463-74.

23.

Calcium dynamics in the failing heart: restoration by beta-adrenergic receptor blockade.

Plank DM, Yatani A, Ritsu H, Witt S, Glascock B, Lalli MJ, Periasamy M, Fiset C, Benkusky N, Valdivia HH, Sussman MA.

Am J Physiol Heart Circ Physiol. 2003 Jul;285(1):H305-15. Epub 2003 Mar 20.

24.

Chronic SR Ca2+-ATPase inhibition causes adaptive changes in cellular Ca2+ transport.

Brittsan AG, Ginsburg KS, Chu G, Yatani A, Wolska BM, Schmidt AG, Asahi M, MacLennan DH, Bers DM, Kranias EG.

Circ Res. 2003 Apr 18;92(7):769-76. Epub 2003 Mar 13.

PMID:
12637367
25.

Desipramine attenuates loss of cardiac sympathetic neurotransmitters produced by congestive heart failure and NE infusion.

Liang CS, Yatani A, Himura Y, Kashiki M, Stevens SY.

Am J Physiol Heart Circ Physiol. 2003 May;284(5):H1729-36. Epub 2003 Jan 23.

26.

Enhanced myocyte contractility and Ca2+ handling in a calcineurin transgenic model of heart failure.

Chu G, Carr AN, Young KB, Lester JW, Yatani A, Sanbe A, Colbert MC, Schwartz SM, Frank KF, Lampe PD, Robbins J, Molkentin JD, Kranias EG.

Cardiovasc Res. 2002 Apr;54(1):105-16.

PMID:
12062367
27.

Type 1 phosphatase, a negative regulator of cardiac function.

Carr AN, Schmidt AG, Suzuki Y, del Monte F, Sato Y, Lanner C, Breeden K, Jing SL, Allen PB, Greengard P, Yatani A, Hoit BD, Grupp IL, Hajjar RJ, DePaoli-Roach AA, Kranias EG.

Mol Cell Biol. 2002 Jun;22(12):4124-35.

28.

Altered excitation-contraction coupling in myocytes from remodeled myocardium after chronic myocardial infarction.

Kim YK, Kim SJ, Kramer CM, Yatani A, Takagi G, Mankad S, Szigeti GP, Singh D, Bishop SP, Shannon RP, Vatner DE, Vatner SF.

J Mol Cell Cardiol. 2002 Jan;34(1):63-73.

PMID:
11812165
29.

Increased myocardial Rab GTPase expression: a consequence and cause of cardiomyopathy.

Wu G, Yussman MG, Barrett TJ, Hahn HS, Osinska H, Hilliard GM, Wang X, Toyokawa T, Yatani A, Lynch RA, Robbins J, Dorn GW 2nd.

Circ Res. 2001 Dec 7;89(12):1130-7.

PMID:
11739277
30.

A novel mechanism for myocardial stunning involving impaired Ca(2+) handling.

Kim SJ, Kudej RK, Yatani A, Kim YK, Takagi G, Honda R, Colantonio DA, Van Eyk JE, Vatner DE, Rasmusson RL, Vatner SF.

Circ Res. 2001 Oct 26;89(9):831-7.

PMID:
11679414
31.

Sarcoplasmic reticulum Ca(2+) atpase (SERCA) 1a structurally substitutes for SERCA2a in the cardiac sarcoplasmic reticulum and increases cardiac Ca(2+) handling capacity.

Lalli MJ, Yong J, Prasad V, Hashimoto K, Plank D, Babu GJ, Kirkpatrick D, Walsh RA, Sussman M, Yatani A, Marbán E, Periasamy M.

Circ Res. 2001 Jul 20;89(2):160-7.

PMID:
11463723
32.

Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure.

Haghighi K, Schmidt AG, Hoit BD, Brittsan AG, Yatani A, Lester JW, Zhai J, Kimura Y, Dorn GW 2nd, MacLennan DH, Kranias EG.

J Biol Chem. 2001 Jun 29;276(26):24145-52. Epub 2001 Apr 27.

33.

[Sarcoidosis with diabetes insipidus and pituitary tumor].

Hattori Y, Hashimoto Y, Matsuoka R, Ohtsuka Y, Nakayama I, Honda Y, Yatani A, Suda K, Sasaki J.

Nihon Naika Gakkai Zasshi. 2001 Feb 10;90(2):326-8. Japanese. No abstract available.

PMID:
11307294
34.

Enhanced Ca2+ channel currents in cardiac hypertrophy induced by activation of calcineurin-dependent pathway.

Yatani A, Honda R, Tymitz KM, Lalli MJ, Molkentin JD.

J Mol Cell Cardiol. 2001 Feb;33(2):249-59.

PMID:
11162130
35.

Rescue of contractile parameters and myocyte hypertrophy in calsequestrin overexpressing myocardium by phospholamban ablation.

Sato Y, Kiriazis H, Yatani A, Schmidt AG, Hahn H, Ferguson DG, Sako H, Mitarai S, Honda R, Mesnard-Rouiller L, Frank KF, Beyermann B, Wu G, Fujimori K, Dorn GW 2nd, Kranias EG.

J Biol Chem. 2001 Mar 23;276(12):9392-9. Epub 2000 Dec 13.

36.

Tails of the L-type Ca(2+) channel: to sense oxygen or not.

Yatani A, Kamp TJ.

Circ Res. 2000 Sep 29;87(7):535-6. No abstract available.

PMID:
11009555
37.

Changes in ionic currents and beta-adrenergic receptor signaling in hypertrophied myocytes overexpressing G alpha(q).

Mitarai S, Reed TD, Yatani A.

Am J Physiol Heart Circ Physiol. 2000 Jul;279(1):H139-48.

38.

Cardiotrophic effects of protein kinase C epsilon: analysis by in vivo modulation of PKCepsilon translocation.

Mochly-Rosen D, Wu G, Hahn H, Osinska H, Liron T, Lorenz JN, Yatani A, Robbins J, Dorn GW 2nd.

Circ Res. 2000 Jun 9;86(11):1173-9.

PMID:
10850970
39.

Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level.

Liggett SB, Tepe NM, Lorenz JN, Canning AM, Jantz TD, Mitarai S, Yatani A, Dorn GW 2nd.

Circulation. 2000 Apr 11;101(14):1707-14.

PMID:
10758054
40.

Mechanisms of impaired beta-adrenergic receptor signaling in G(alphaq)-mediated cardiac hypertrophy and ventricular dysfunction.

Dorn GW 2nd, Tepe NM, Wu G, Yatani A, Liggett SB.

Mol Pharmacol. 2000 Feb;57(2):278-87.

PMID:
10648637
41.

Myocardial beta-adrenoceptor down-regulation by norepinephrine is linked to reduced norepinephrine uptake activity.

Dong E, Yatani A, Mohan A, Liang CS.

Eur J Pharmacol. 1999 Nov 12;384(1):17-24.

PMID:
10611414
42.
43.

Behavioral and hormonal basis of polygynous breeding in male bush warblers (Cettia diphone).

Wada M, Shimizu T, Kobayashi S, Yatani A, Sandaiji Y, Ishikawa T, Takemure E.

Gen Comp Endocrinol. 1999 Dec;116(3):422-32.

PMID:
10603280
44.

ACE inhibition improves cardiac NE uptake and attenuates sympathetic nerve terminal abnormalities in heart failure.

Kawai H, Fan TH, Dong E, Siddiqui RA, Yatani A, Stevens SY, Liang CS.

Am J Physiol. 1999 Oct;277(4):H1609-17. doi: 10.1152/ajpheart.1999.277.4.H1609.

PMID:
10516201
45.

Cardiac-specific overexpression of Galphaq alters excitation-contraction coupling in isolated cardiac myocytes.

Yatani A, Frank K, Sako H, Kranias EG, Dorn GW 2nd.

J Mol Cell Cardiol. 1999 Jul;31(7):1327-36.

PMID:
10403750
47.

Differential regulation of inotropy and lusitropy in overexpressed Gsalpha myocytes through cAMP and Ca2+ channel pathways.

Kim SJ, Yatani A, Vatner DE, Yamamoto S, Ishikawa Y, Wagner TE, Shannon RP, Kim YK, Takagi G, Asai K, Homcy CJ, Vatner SF.

J Clin Invest. 1999 Apr;103(7):1089-97.

48.

Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice.

Sato Y, Ferguson DG, Sako H, Dorn GW 2nd, Kadambi VJ, Yatani A, Hoit BD, Walsh RA, Kranias EG.

J Biol Chem. 1998 Oct 23;273(43):28470-7.

49.

Overexpression of phospholamban alters inactivation kinetics of L-type Ca2+ channel currents in mouse atrial myocytes.

Masaki H, Sako H, Kadambi VJ, Sato Y, Kranias EG, Yatani A.

J Mol Cell Cardiol. 1998 Feb;30(2):317-25.

PMID:
9515008
50.

Supplemental Content

Loading ...
Support Center